On Friday, Morgan Stanley raised its recommendation on Bureau Veritas shares to "overweight", from "in-line weighting", with a price target raised from $27.5 to $28.5.

In a study devoted to the professional services sector, the broker notes that the inspection and certification specialist's share price fell last year, despite an improvement in organic growth.

The broker attributes this decline to a business mix considered less buoyant, and to an unfavorable currency effect.

However, it expects the Group's next investor day, scheduled for March 20, to act as a catalyst, with the presentation of new medium-term targets.

With the stock now trading at a PER 2024 of around 17x, despite expected organic growth of 5%, a solid balance sheet and upside potential of over 25% compared with our target price, we are upgrading our recommendation to 'Overweight'," concludes the professional.

Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.